申请人:Ciba-Geigy Corporation
公开号:US04622322A1
公开(公告)日:1986-11-11
Compounds of the formula ##STR1## wherein Ar is pyridyl or phenyl substituted by halogen, halo-C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -alkoxy, or carboxy-C.sub.1 -C.sub.4 -alkyl, n is zero, one or two, R.sub.1 is hydrogen, C.sub.1 -C.sub.4 -alkyl, heterocyclyl-C.sub.2 -C.sub.4 -alkyl, amino-C.sub.2 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -alkylamino-C.sub.2 -C.sub.4 -alkyl, di-C.sub.1 -C.sub.4 -alkylamino-C.sub.2 -C.sub.4 -alkylor C.sub.1 -C.sub.4 -alkanoyl, and R.sub.2 is hydrogen, carboxy-C.sub.1 -C.sub.4 -alkyl, or C.sub.1 -C.sub.4 -alkoxy-carbonyl-C.sub.1 -C.sub.4 -alkyl are disclosed as well as their preparation, pharmaceutical compositions containing the same and the use thereof as antirheumatic agents.
该化合物的公式为##STR1##其中Ar是取代有卤素,卤基-C.sub.1-C.sub.4-烷基,C.sub.1-C.sub.4-烷氧基或羧基-C.sub.1-C.sub.4-烷基的吡啶基或苯基,n为零,一或二,R.sub.1是氢,C.sub.1-C.sub.4-烷基,杂环基-C.sub.2-C.sub.4-烷基,氨基-C.sub.2-C.sub.4-烷基,C.sub.1-C.sub.4-烷基氨基-C.sub.2-C.sub.4-烷基,双-C.sub.1-C.sub.4-烷基氨基-C.sub.2-C.sub.4-烷基或C.sub.1-C.sub.4-酰基,R.sub.2是氢,羧基-C.sub.1-C.sub.4-烷基或C.sub.1-C.sub.4-烷氧基-羧酸-C.sub.1-C.sub.4-烷基,以及它们的制备方法、含有它们的制药组合物和作为抗风湿药物的用途。